Allarity Acquisition Corp.

S-1/A amended

Price $10.00 · 8,000,000 shares · Gross proceeds $79,600,000

Allarity Acquisition Corp. is a blank check company aiming to merge with a life sciences or biotechnology business. The IPO involves 8 million units at $10.00 per unit, with underwriters Maxim Group LLC. Lock-up agreements restrict insiders from selling shares for 180 days, and a tail fee structure incentivizes underwriters if subsequent financings occur within 12 months. Proceeds will be held in a trust account, with risks including market volatility, lack of operating history, and reliance on underwriters.

S-1/A amended

Price $10.00 · 8,000,000 shares · Gross proceeds $80,000,000

Allarity Acquisition Corp. is a blank check company targeting a business combination, likely in life sciences or biotechnology. The IPO involves 10 million units at $10.00 each, with underwriters Maxim Group LLC. Key terms include lock-up agreements for shares and warrants, a tail fee for future financings, and listing on Nasdaq. The company has not yet identified a target and faces risks related to market volatility and trust account liabilities.

S-1/A amended

Price $10.00 · 10,000,000 shares · Gross proceeds $100,000,000

Allarity Acquisition Corp. is conducting an IPO with units priced at $10.00, underwritten by Maxim. The offering includes a 45-day over-allotment option for 1.5M additional units. Lock-up agreements restrict sales of units, warrants, and shares for 180 days, with potential release if the stock price meets thresholds. The company plans to list on Nasdaq under 'ALLNU,' with Class A shares and warrants to follow. Underwriters receive $0.05 per unit in discounts and $25K in expenses. A 'tail fee' of 5% of future financing proceeds is payable to Maxim. Electronic distribution methods and regulatory restrictions are outlined.

S-1 filed

Price $10.00 · 10,000,000 shares · Gross proceeds $100,000,000

Allarity Acquisition Corp. is a special purpose acquisition company (SPAC) conducting an IPO to raise capital for a future business combination. The filing outlines the structure of the offering, including founder shares, private warrants, and lock-up periods for insiders. Key elements include restrictions on share transfers, potential conflicts of interest due to insider ownership, and risks associated with the inability to complete a business combination, which could lead to liquidation. The sponsor, Allarity, and management team have financial incentives tied to completing a merger, which may diverge from public shareholders' interests. The document also details voting agreements, reimbursement of expenses, and the role of underwriters like Maxim.

DRS filed

Allarity Acquisition Corp. is conducting a public offering of units, with underwriters reserving the right to adjust offers and reject orders. The underwriters have an option to purchase additional units for 45 days to cover over-allotments. Lock-up agreements restrict insiders from selling securities for 180 days, with potential exemptions. The company plans to list units on Nasdaq, though no guarantee is provided. A tail fee of 5% of gross proceeds from future financings within 12 months is outlined, payable to Maxim as underwriter. The offering includes underwriting discounts, expenses, and registration rights for shares issued to Maxim.